In a vote of 61-3, a key Food and Drug Administration (FDA) panel rejected a plan to approve Pfizer booster shots.
In a vote of 61-3, a key Food and Drug Administration (FDA) panel rejected a plan to approve Pfizer booster shots.
FDA panel set to consider Pfizer COVID-19 vaccine booster shots on Friday